New 'Bottom-Up' surgery for rectal cancer could mean faster recovery

NCT ID NCT02584985

Completed Disease control Sponsor: Institut Paoli-Calmettes Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a newer, less invasive surgery called ETAP (done through the anus) against standard laparoscopic surgery (done through the belly) for low rectal cancer. 226 adults took part. The goal was to see if ETAP is as good at removing all cancer while possibly leading to fewer complications and a quicker recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Endoscopic Transanal Proctectomy (ETAP) surgery
What this could lead to: If successful, ETAP could offer a less invasive surgical option for low rectal cancer with fewer complications and better recovery.
What could go wrong: This is a completed trial, but results may not apply to all patients. The new technique may not be as effective at removing all cancer or could have unknown long-term risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rectal cancer rectal neoplasm rectum adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RECTAL CANCER

Contacts and locations

Locations

Institut Paoli-Calmettes

Marseille, 13009, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.